Chang Je-Ken, Wu Shun-Cheng, Wang Gwo-Jaw, Cho Ming-Hsuang, Ho Mei-Ling
Department of Orthopaedics, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Toxicology. 2006 Dec 7;228(2-3):111-23. doi: 10.1016/j.tox.2006.08.028. Epub 2006 Aug 30.
Previous reports indicated that non-steroidal anti-inflammatory drugs (NSAIDs) suppress bone repair. Our previous study further found that ketorolac delayed the endochondral bone formation, and the critical effective timing was at the early stage of repair. Furthermore, we found that NSAIDs suppressed proliferation and induced cell death of cultured osteoblasts. In this study, we hypothesized that chondrocytic proliferation and death, which plays an important role at the early stage of endochondral bone formation, might be affected by NSAIDs. Non-selective NSAIDs, indomethacin, ketorolac, diclofenac and piroxicam; cyclooxygenase-2 (COX-2) selective NSAIDs, celecoxib and DFU (an analog of rofecoxib); prostaglandins (PGs), PGE1, PGE2 and PGF2alpha; and each NSAID plus each PG were tested. The effects of NSAIDs on proliferation, cell cycle kinetics, cytotoxicity and cell death of epiphyseal-articular chondrocytes of fetal rats were examined. The results showed that all the tested NSAIDs, except DFU, inhibited thymidine incorporation of chondrocytes at a concentration range (10(-8) to 10(-4)M) covering the theoretic therapeutic concentrations. Cell cycle was arrested by NSAIDs at the G(0)/G(1) phase. Upon a 24h treatment, LDH leakage and cell death (both apoptosis and necrosis) were significantly induced by the four non-selective NSAIDs in chondrocyte cultures. However, COX-2 inhibitors revealed non-significant effects on cytotoxicity of chondrocytes except higher concentration of celecoxib (10(-4)M). Replenishments of PGE1, PGE2 or PGF2alpha could not reverse the effects of NSAIDs on chondrocytic proliferation and cytotoxicity. In this study, we found that therapeutic concentrations of non-selective NSAIDs caused proliferation suppression and cell death of chondrocytes, suggesting these adverse effects may be one of the reasons that NSAIDs delay the endochondral ossification during bone repair found in previous studies. Furthermore, these effects of NSAIDs may act via PG-independent mechanisms. COX-2 selective NSAIDs showed less deleterious effects on chondrocytic proliferation and death.
以往的报告表明,非甾体抗炎药(NSAIDs)会抑制骨修复。我们之前的研究进一步发现,酮咯酸会延迟软骨内骨形成,关键的有效时间点是在修复的早期阶段。此外,我们发现NSAIDs会抑制培养的成骨细胞的增殖并诱导其死亡。在本研究中,我们假设在软骨内骨形成早期起重要作用的软骨细胞增殖和死亡可能会受到NSAIDs的影响。对非选择性NSAIDs吲哚美辛、酮咯酸、双氯芬酸和吡罗昔康;环氧合酶-2(COX-2)选择性NSAIDs塞来昔布和DFU(罗非昔布类似物);前列腺素(PGs),PGE1、PGE2和PGF2α;以及每种NSAIDs加每种PG进行了测试。研究了NSAIDs对胎鼠骨骺关节软骨细胞增殖、细胞周期动力学、细胞毒性和细胞死亡的影响。结果表明,除DFU外,所有测试的NSAIDs在覆盖理论治疗浓度的浓度范围(10^(-8)至10^(-4)M)内均抑制软骨细胞的胸苷掺入。NSAIDs使细胞周期停滞在G(0)/G(1)期。经过24小时处理后,四种非选择性NSAIDs在软骨细胞培养物中显著诱导乳酸脱氢酶(LDH)泄漏和细胞死亡(包括凋亡和坏死)。然而,COX-2抑制剂对软骨细胞的细胞毒性显示无显著影响,除了较高浓度的塞来昔布(10^(-4)M)。补充PGE1、PGE2或PGF2α不能逆转NSAIDs对软骨细胞增殖和细胞毒性的影响。在本研究中,我们发现治疗浓度的非选择性NSAIDs会导致软骨细胞增殖抑制和细胞死亡,表明这些不良反应可能是先前研究中NSAIDs延迟骨修复过程中软骨内骨化的原因之一。此外,NSAIDs的这些作用可能通过不依赖PG的机制发挥。COX-2选择性NSAIDs对软骨细胞增殖和死亡的有害影响较小。